WASHINGTON—On their first day back from summer recess, House lawmakers passed a flurry of China-related legislation. Two noteworthy bills require the backlisting of Chinese biotech firms and funding for the State Department to coordinate efforts to counter the Chinese regime’s malign influence.
Amid other priorities, most notably the pressure to pass spending bills, the House voted in a bipartisan manner to add a “China Week” to the calendar. The widespread support is indicative of the congressional consensus that the Chinese communist regime poses the most significant national security risk to the values of the United States.